CRISPR/Cas9 gene editing: New hope for Alzheimer's disease therapeutics

BACKGROUND: Alzheimer's disease (AD) is an insidious, irreversible, and progressive neurodegenerative health condition manifesting as cognitive deficits and amyloid beta (Aβ) plaques and neurofibrillary tangles. Approximately 50 million individuals are affected by AD, and the number is rapidly...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhardwaj, Shanu, Kesari, Kavindra Kumar, Rachamalla, Mahesh, Mani, Shalini, Ashraf, Ghulam Md., Jha, Saurabh Kumar, Kumar, Pravir, Ambasta, Rashmi K., Dureja, Harish, Devkota, Hari Prasad, Gupta, Gaurav, Chellappan, Dinesh Kumar, Singh, Sachin Kumar, Dua, Kamal, Ruokolainen, Janne, Kamal, Mohammad Amjad, Ojha, Shreesh, Jha, Niraj Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481950/
https://www.ncbi.nlm.nih.gov/pubmed/36100328
http://dx.doi.org/10.1016/j.jare.2021.07.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481950/
https://www.ncbi.nlm.nih.gov/pubmed/36100328
http://dx.doi.org/10.1016/j.jare.2021.07.001

Ejemplares similares